Navigation Links
Michael J. Fox Foundation PD Therapeutics Conference
Date:8/7/2008

The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host its second annual PD Therapeutics Conference on Monday, September 15, in Chicago.

Chaired by Jeffrey Kordower, PhD, Director, Research Center for Brain Repair and Jean-Schweppe Armour Professor of Neurological Sciences at Rush University Medical Center, the conference will bring together academic and industry scientists to focus on novel research advances impacting development of improved disease-modifying and symptomatic interventions for the diagnosis and treatment of PD.

Select MJFF-funded investigators will present research on topics including novel neuroprotective agents, innovative mechanisms to address disease symptoms and improvements in relevant animal models, and biomarker discovery/development.

In addition to scientific talks, a small poster session will highlight novel targets and animal models relevant to PD research.

Confirmed speakers include:

  • D. James Surmeier, PhD (Northwestern University), on the FDA-approved diabetes drug that may protect dopamine neurons in the Parkinson's brain

  • Anders Bjrkund, MD, PhD (Lund University, Sweden), on the role of serotonin (better known for the part it plays in depression) in dyskinesias, the disruptive movements brought on by long-term dopamine replacement therapy

  • Erwan Bezard, PhD (Universite Victor Segalen, Bordeaux, France), and Piu Chan, MD, PhD (Beijing Institute of Geriatrics, China), on conducting pre-clinical and clinical research in China

  • Patrik Brundin, MD, PhD (Lund University, Sweden), on the state of cell replacement approaches for Parkinson's disease

Registration is free for accredited members of the press.

Last year's inaugural conference in New York City drew a multidisciplinary audience of nearly 200 academic, pharmaceutical and biotechnology industry researchers.


'/>"/>

Contact: Holly Barkhymer
hbarkhymer@michaeljfox.org
212-509-0995 x242
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

Page: 1

Related biology news :

1. [video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.nets 3-Minute Press Show
2. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
3. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
4. Neuroscientist Michael Gazzaniga awarded Humboldt Prize
5. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
6. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
7. American Society for Microbiology honors Michael Bruce Zwick
8. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
9. W.M. Keck Foundation grant funds reproductive science research
10. W.M. Keck Foundation announces 2008 class of Distinguished Young Scholars in Medical Research
11. Glenn Foundation for Medical Research commits $5 million to study aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
Breaking Biology Technology: